• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 91 of 100
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance
Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By Laura LorenzettiOctober 12, 2015
General Views of Eli Lilly & Co.
Health
Why drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Hedge fund manager Bill Ackman
Finance
The strange thing about Bill Ackman’s defense of Valeant’s drug prices
By Stephen GandelOctober 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
Health
AmerisourceBergen pays $2.58 billion to buy PharMEDium
By Laura LorenzettiOctober 6, 2015
Symbolic - biotechnology - genetic engineering
Health
TPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Japan Scenics
Health
This Japanese pufferfish could be the ultimate painkiller
By Laura LorenzettiSeptember 30, 2015
Why drug price controversy is great news for this hedge fund manager
Finance
Why drug price controversy is great news for this hedge fund manager
By Jen WiecznerSeptember 30, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Health
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health
Biotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
Leadership
Donald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
Inside Teva Pharmaceuticals Headquarters
Health
Here are the 5 drug classes with the biggest price gains
By Laura LorenzettiSeptember 23, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
Health
Doctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
HIllary Rodham Clinton
Health
Hillary Clinton releases health plan that aims to combat skyrocketing drug costs
By Laura LorenzettiSeptember 22, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Here’s why Turing Pharmaceuticals says 5,000% price bump is necessary
By Laura LorenzettiSeptember 21, 2015
1...
  • 89
  • 90
  • 91
  • 92
  • 93
...100
Most Popular
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.